Global Crohn's Disease Treatment Market Is Estimated To Witness Growth Due To Increasing Technological Advancement And Growing Prevalence Of Chronic Disease

Crohn's Disease Treatment Market
 Crohn's Disease Treatment Market

Overview:

Crohn's disease affects the gastrointestinal (GI) tract. Its symptoms can range from mild to severe. The condition is usually diagnosed after ruling out other possible causes. An upper GI endoscopy can be done to examine the lining of the small intestine. A balloon-assisted enteroscopy is an option for patients with suspected abnormalities.

Although there is no known cure, a number of treatments can help control symptoms and reduce complications. Medications may be used to relieve inflammation. This can relieve some of the more common symptoms of Crohn's disease, such as abdominal pain and diarrhea. Some medications can also be used to prevent infections. Lifestyle changes can help decrease Crohn's symptoms. These include exercise, staying hydrated, and changing diet.

Market Dynamics:

Growing partnerships among key players is anticipated to propel growth of the global Crohn's Disease Treatment Market over the forecast period. For instance, an Israeli technology start-up CytoReason, partnered up with a Switzerland-based multinational pharmaceutical company Ferring Pharmaceuticals in May 2021. This partnership is aiming to develop new inflammatory bowel disease treatments using artificial intelligence technology. Moreover, lack of awareness regarding treatment options is estimated to hinder growth of the global Crohn's disease treatment for market over the forecast period.

Impact of COVID-19:

The pandemic was first reported in China in 2019 and it was then transmitted to many nations. IN 2020, this outbreak was declared as a public health emergency by the World Health Organization. This outbreak affected many nations like China, India, the US, Spain, Italy, France, Australia, UAE, and many more. The healthcare facilities of many nations was under immense pressure while battling the virus. This led to prioritizing COVID-19 patients over other diseases. Many hospitals were running on full capacity, so patients suffering from other diseases were either treated remotely or the treatments were postponed. This had a negative impact on the global Crohn's Disease Treatment Market. However, in the post-pandemic ear conditions are much better and the market is estimated to witness growth again.

Key Takeaways:

The global Crohn's Disease Treatment Market is anticipated to witness significant growth, exhibiting CAGR at high rate over the forecast period, owing to growing product approvals.

For instance, a biopharmaceutical company, AbbVie Inc., declared that the .S. Food and Drug Administration has approved their first and only specific interleukin-23 (IL-23) inhibitor SKYRIZI in June 2022. North America is anticipated to witness significant growth in the global Crohn's disease treatment market over the forecast period, due growing presence of advanced healthcare infrastructure and rising awareness regarding oral health in the region.

Major players operating in the global Crohn's disease treatment for market are AbbVie Inc., Amgen Inc., AstraZeneca, Janssen Biotech, Inc., Mylan N.V., Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Ltd, Boehringer Ingelheim GmbH, Sanofi, Pfizer Inc., Novartis AG, and Eli Lilly and Company.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more

Patient-Centered Medical Home; Is Used To Offer High-Standard, Inexpensive Primary Care

Image
Patient-Centered Medical Home The Patient-Centered Medical Home is a care model in which individuals are involved in a direct association with a chosen physician who organizes a supportive team of hospital experts, takes cooperative accountability for the comprehensive incorporated care offered to the patient, and sponsors and arranges suitable care with other professional physicians and community sources as per requirements. Use of PCMH develop disciplinary care teams to enhance care management and care administration of patient populaces focusing to increase safety, efficacy and standard in patient care. PCMH practices can enhance care and take benefits of private or public inducement payments that are offered to patients. The Patient Protection and Affordable Care Act (ACA) provides extra federal expenditure to regions for health homes helping Medicaid receivers. Supplier groups and hospitals can visit their federal and state officials and private insurers’ websites for data on exp
Read more